pyrimethamine has been researched along with Trypanosomiasis, African in 5 studies
Maloprim: contains above 2 cpds
Trypanosomiasis, African: A disease endemic among people and animals in Central Africa. It is caused by various species of trypanosomes, particularly T. gambiense and T. rhodesiense. Its second host is the TSETSE FLY. Involvement of the central nervous system produces African sleeping sickness. Nagana is a rapidly fatal trypanosomiasis of horses and other animals.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chowdhury, SF | 1 |
| Villamor, VB | 1 |
| Guerrero, RH | 1 |
| Leal, I | 1 |
| Brun, R | 1 |
| Croft, SL | 1 |
| Goodman, JM | 1 |
| Maes, L | 1 |
| Ruiz-Perez, LM | 1 |
| Pacanowska, DG | 1 |
| Gilbert, IH | 1 |
| Tulloch, LB | 1 |
| Martini, VP | 1 |
| Iulek, J | 1 |
| Huggan, JK | 1 |
| Lee, JH | 1 |
| Gibson, CL | 1 |
| Smith, TK | 1 |
| Suckling, CJ | 1 |
| Hunter, WN | 1 |
| Woodruff, AW | 1 |
| Foote, SJ | 1 |
| Iraqi, F | 1 |
| Kemp, SJ | 1 |
| Payet, M | 1 |
| Coulaud, JP | 1 |
| Pasticier, A | 1 |
| Saimot, G | 1 |
2 reviews available for pyrimethamine and Trypanosomiasis, African
| Article | Year |
|---|---|
Recent work concerning anemia in the tropics.
Topics: Adolescent; Adult; Anemia; Anemia, Hypochromic; Anemia, Megaloblastic; Animals; Child; Child, Presch | 1982 |
Controlling malaria and African trypanosomiasis: the role of the mouse.
Topics: Animals; Disease Models, Animal; Disease Progression; Drug Resistance; Genetic Linkage; Genetic Pred | 2005 |
3 other studies available for pyrimethamine and Trypanosomiasis, African
| Article | Year |
|---|---|
Design, synthesis, and evaluation of inhibitors of trypanosomal and leishmanial dihydrofolate reductase.
Topics: Animals; Drug Design; Folic Acid Antagonists; Humans; In Vitro Techniques; Leishmania infantum; Leis | 1999 |
Structure-based design of pteridine reductase inhibitors targeting African sleeping sickness and the leishmaniases.
Topics: Catalytic Domain; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Leishmania major | 2010 |
[Tropical and parasitic diseases].
Topics: Acute Kidney Injury; Amebiasis; Antimalarials; Cholera; Drug Resistance, Microbial; Encephalitis; Gl | 1974 |